Making immunotherapy more effective against small cell lung cancer

Fred Hutchinson Cancer Center lung cancer scientists open a human trial after preclinical work shows that making small cell lung cancer more visible to immune cells can make the tumors more responsive to immunotherapy.

Related Keywords

New York ,United States ,Rafael Santana Davila ,University Of Washington ,Hutch Specialized Program Of Research Excellence ,Cancer Act ,Specialized Program ,Research Excellence ,Imago Biosciences ,Imago Bioscience ,With Hutch ,Immunotherapy ,David Macpherson ,Small Cell Lung Cancer ,Chromatin Modification ,Human Biology ,Clinical Trial ,